Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cost Effectiveness and Resource Allocation
Published in: Cost Effectiveness and Resource Allocation 1/2012

Open Access 01-12-2012 | Review

From efficacy to equity: Literature review of decision criteria for resource allocation and healthcare decisionmaking

Authors: Lalla Aïda Guindo, Monika Wagner, Rob Baltussen, Donna Rindress, Janine van Til, Paul Kind, Mireille M Goetghebeur

Published in: Cost Effectiveness and Resource Allocation | Issue 1/2012

Login to get access

Abstract

Objectives

Resource allocation is a challenging issue faced by health policy decisionmakers requiring careful consideration of many factors. Objectives of this study were to identify decision criteria and their frequency reported in the literature on healthcare decisionmaking.

Method

An extensive literature search was performed in Medline and EMBASE to identify articles reporting healthcare decision criteria. Studies conducted with decisionmakers (e.g., focus groups, surveys, interviews), conceptual and review articles and articles describing multicriteria tools were included. Criteria were extracted, organized using a classification system derived from the EVIDEM framework and applying multicriteria decision analysis (MCDA) principles, and the frequency of their occurrence was measured.

Results

Out of 3146 records identified, 2790 were excluded. Out of 356 articles assessed for eligibility, 40 studies included. Criteria were identified from studies performed in several regions of the world involving decisionmakers at micro, meso and macro levels of decision and from studies reporting on multicriteria tools. Large variations in terminology used to define criteria were observed and 360 different terms were identified. These were assigned to 58 criteria which were classified in 9 different categories including: health outcomes; types of benefit; disease impact; therapeutic context; economic impact; quality of evidence; implementation complexity; priority, fairness and ethics; and overall context. The most frequently mentioned criteria were: equity/fairness (32 times), efficacy/effectiveness (29), stakeholder interests and pressures (28), cost-effectiveness (23), strength of evidence (20), safety (19), mission and mandate of health system (19), organizational requirements and capacity (17), patient-reported outcomes (17) and need (16).

Conclusion

This study highlights the importance of considering both normative and feasibility criteria for fair allocation of resources and optimized decisionmaking for coverage and use of healthcare interventions. This analysis provides a foundation to develop a questionnaire for an international survey of decisionmakers on criteria and their relative importance. The ultimate objective is to develop sound multicriteria approaches to enlighten healthcare decisionmaking and priority-setting.
Appendix
Available only for authorised users
Literature
1.
Hsu M, Anen C, Quartz SR: The right and the good: distributive justice and neural encoding of equity and efficiency. Science 2008, 320: 1092–1095. 10.1126/science.1153651PubMedCrossRef
2.
3.
4.
Gruskin S, Daniels N: Process is the point: justice and human rights: priority setting and fair deliberative process. Am J Public Health 2008, 98: 1573–1577. 10.2105/AJPH.2007.123182PubMedCentralPubMedCrossRef
5.
Persad G, Wertheimer A, Emanuel EJ: Principles for allocation of scarce medical interventions. Lancet 2009, 373: 423–431. 10.1016/S0140-6736(09)60137-9PubMedCrossRef
6.
Daniels N, Sabin J: Limits to health care: fair procedures, democratic deliberation, and the legitimacy problem for insurers. Philos Public Aff 1997, 26: 303–350. 10.1111/j.1088-4963.1997.tb00082.xPubMedCrossRef
7.
8.
Asante AD, Zwi AB: Factors influencing resource allocation decisions and equity in the health system of Ghana. Public Health 2009, 123: 371–377. 10.1016/j.puhe.2009.02.006PubMedCrossRef
9.
Andreae MC, Lamarand KE, Abraham L, Freed GL: Basis for immunization recommendations among countries of the worldHealth Organization European region. Hum Vaccin 2009, 5: 754–760. 10.4161/hv.5.11.9829PubMedCrossRef
10.
Goetghebeur MM, Wagner M, Khoury H, Rindress D, Gregoire JP, Deal C: Combining multicriteria decision analysis, ethics and health technology assessment: applying the EVIDEM decisionmaking framework to growth hormone for Turner syndrome patients. Cost Eff Resour Alloc 2010, 8: 4. 10.1186/1478-7547-8-4PubMedCentralPubMedCrossRef
11.
Baltussen R, Niessen L: Priority setting of health interventions: the need for multi-criteria decision analysis. Cost Eff Resour Alloc 2006, 4: 14. 10.1186/1478-7547-4-14PubMedCentralPubMedCrossRef
12.
Baltussen R, ten Asbroek AH, Koolman X, Shrestha N, Bhattarai P, Niessen LW: Priority setting using multiple criteria: should a lung health programme be implemented in Nepal? Health Policy Plan 2007, 22: 178–185. 10.1093/heapol/czm010PubMedCrossRef
13.
Youngkong S, Kapiriri L, Baltussen R: Setting priorities for health interventions in developing countries: a review of empirical studies. Trop Med Int Health 2009, 14: 930–939. 10.1111/j.1365-3156.2009.02311.xPubMedCrossRef
14.
15.
16.
Browman GP, Manns B, Hagen N, Chambers CR, Simon A, Sinclair S: 6-STEPPPs: A modular tool to facilitate clinician participation in fair decisions for funding new cancer drugs. Journal of Oncology Practice 2008, 4: 2–7. 10.1200/JOP.0812001PubMedCentralPubMedCrossRef
17.
Ghaffar A: Setting research priorities by applying the combined approach matrix. Indian J Med Res 2009, 129: 368–375.PubMed
18.
Goetghebeur M, Wagner M, Khoury H, Levitt RJ, Erickson LJ, Rindress D: Evidence and Value: Impact on DEcisionMaking - the EVIDEM framework and potential applications. BMC Health Serv Res 2008, 8: 270. 10.1186/1472-6963-8-270PubMedCentralPubMedCrossRef
19.
Golan OG, Hansen P: A new decision-support framework for prioritization of new health technologies. The 'value for money' chart, University of Otago; 2010.
20.
Hailey D: A preliminary survey on the influence of rapid health technology assessments. Int J Technol Assess Health Care 2009, 25: 415–418. 10.1017/S0266462309990067PubMedCrossRef
21.
Honore PA, Fos PJ, Smith T, Riley M, Kramarz K: Decision science: a scientific approach to enhance public health budgeting. J Public Health Manag Pract 2010, 16: 98–103.PubMedCrossRef
22.
Johnson AP, Sikich NJ, Evans G, Evans W, Giacomini M, Glendining M, et al.: Health technology assessment: a comprehensive framework for evidence-based recommendations in Ontario. Int J Technol Assess Health Care 2009, 25: 141–150. 10.1017/S0266462309090199PubMedCrossRef
23.
Kirby J, Somers E, Simpson C, McPhee J: The public funding of expensive cancer therapies: synthesizing the "3Es"–evidence, economics, and ethics. Organ Ethic 2008, 4: 97–108.PubMed
24.
Meagher T: MUHC clinical activity priority setting A4R and beyond. Presented at the 8th Biennial Conference of the International Society on Priorities in Health Care, Boston; 2010.
25.
Menon D, Stafinski T, McCabe C: To fund or not to fund: A generalized decision-making model for health care resource allocation. Presented at the 8th Biennial Conference of the International Society on Priorities in Health Care, Boston; 2010.
26.
Tannahill A: Beyond evidence–to ethics: a decision-making framework for health promotion, public health and health improvement. Health Promot Int 2008, 23: 380–390. 10.1093/heapro/dan032PubMedCrossRef
27.
28.
Wilson EC, Rees J, Fordham RJ: Developing a prioritisation framework in an English Primary Care Trust. Cost Eff Resour Alloc 2006, 4: 3. 10.1186/1478-7547-4-3PubMedCentralPubMedCrossRef
29.
30.
Baltussen R, Stolk E, Chisholm D, Aikins M: Towards a multi-criteria approach for priority setting: an application to Ghana. Health Econ 2006, 15: 689–696. 10.1002/hec.1092PubMedCrossRef
31.
Dionne F, Mitton C, Smith N, Donaldson C: Evaluation of the impact of program budgeting and marginal analysis in Vancouver Island Health Authority. J Health Serv Res Policy 2009, 14: 234–242. 10.1258/jhsrp.2009.008182PubMedCrossRef
32.
Dolan JG: Multi-criteria clinical decision support. A primer on the use of multiple-criteria decision-making methods to promote evidence-based, patient-centered healthcare. Patient 2010, 3: 229–248. 10.2165/11539470-000000000-00000PubMedCentralPubMedCrossRef
33.
Duthie T, Trueman P, Chancellor J, Diez L: Research into the use of health economics in decision making in the United Kingdom--Phase II. Is health economics 'for good or evil'? Health Policy 1999, 46: 143–157. 10.1016/S0168-8510(98)00057-8PubMedCrossRef
34.
Gibson J, Mitton C, Martin D, Donaldson C, Singer P: Ethics and economics: does programme budgeting and marginal analysis contribute to fair priority setting? J Health Serv Res Policy 2006, 11: 32–37. 10.1258/135581906775094280PubMedCrossRef
35.
Hofmann B: Toward a procedure for integrating moral issues in health technology assessment. Int J Technol Assess Health Care 2005, 21: 312–318.PubMedCrossRef
36.
Irving MJ, Tong A, Rychetnik L, Walker RG, Frommer MS, Craig JC: Nephrologists' perspectives on the effect of guidelines on clinical practice: a semistructured interview study. Am J Kidney Dis 2010, 55: 241–249. 10.1053/j.ajkd.2009.09.032PubMedCrossRef
37.
Jehu-Appiah C, Baltussen R, Acquah C, Aikins M, D'Almeida SA, Bosu WK, et al.: Balancing equity and efficiency in health priorities in Ghana: the use of multicriteria decision analysis. Value Health 2008, 11: 1081–1087. 10.1111/j.1524-4733.2008.00392.xPubMedCrossRef
38.
Kapiriri L, Norheim OF, Martin DK: Fairness and accountability for reasonableness. Do the views of priority setting decision makers differ across health systems and levels of decision making? Soc Sci Med 2009, 68: 766–773. 10.1016/j.socscimed.2008.11.011PubMedCrossRef
39.
Koopmanschap MA, Stolk EA, Koolman X: Dear policy maker: have you made up your mind? A discrete choice experiment among policy makers and other health professionals. Int J Technol Assess Health Care 2010, 26: 198–204. 10.1017/S0266462310000048PubMedCrossRef
40.
Lehoux P, Williams-Jones B: Mapping the integration of social and ethical issues in health technology assessment. Int J Technol Assess Health Care 2007, 23: 9–16.PubMedCrossRef
41.
Lopert R: Evidence-based decision-making within Australia's pharmaceutical benefits scheme. Issue Brief (Commonw Fund) 2009, 60: 1–13.
42.
Martin DK, Pater JL, Singer PA: Priority-setting decisions for new cancer drugs: a qualitative case study. Lancet 2001, 358: 1676–1681. 10.1016/S0140-6736(01)06714-9PubMedCrossRef
43.
Mitton C, Mackenzie J, Cranston L, Teng F: Priority setting in the Provincial Health Services Authority: case study for the 2005/06 planning cycle. Healthc Policy 2006, 2: 91–106.PubMedCentralPubMed
44.
Mullen PM: Quantifying priorities in healthcare: transparency or illusion? Health Serv Manage Res 2004, 17: 47–58. 10.1258/095148404322772723PubMedCrossRef
45.
Noorani HZ, Husereau DR, Boudreau R, Skidmore B: Priority setting for health technology assessments: a systematic review of current practical approaches. Int J Technol Assess Health Care 2007, 23: 310–315.PubMedCrossRef
46.
Saarni SI, Hofmann B, Lampe K, Luhmann D, Makela M, Velasco-Garrido M, et al.: Ethical analysis to improve decision-making on health technologies. Bull World Health Organ 2008, 86: 617–623. 10.2471/BLT.08.051078PubMedCentralPubMedCrossRef
47.
Vuorenkoski L, Toiviainen H, Hemminki E: Decision-making in priority setting for medicines–a review of empirical studies. Health Policy 2008, 86: 1–9. 10.1016/j.healthpol.2007.09.007PubMedCrossRef
48.
Wilson E, Sussex J, Macleod C, Fordham R: Prioritizing health technologies in a Primary Care Trust. J Health Serv Res Policy 2007, 12: 80–85. 10.1258/135581907780279495PubMedCrossRef
49.
Wirtz V, Cribb A, Barber N: Reimbursement decisions in health policy–extending our understanding of the elements of decision-making. Health Policy 2005, 73: 330–338. 10.1016/j.healthpol.2004.12.002PubMedCrossRef
50.
Gibson JL, Martin DK, Singer PA: Evidence, economics and ethics: resource allocation in health services organizations. Healthc Q 2005, 8: 50–9. 4PubMedCrossRef
51.
Bowen S, Erickson T, Martens PJ, Crockett S: More Than "Using Research": The Real Challenges in Promoting Evidence-Informed Decision-Making. Healthc Policy 2009, 4: 87–102.PubMedCentralPubMed
52.
Wilson KA, Carwardine J, Possingham HP: Setting conservation priorities. Ann N Y Acad Sci 2009, 1162: 237–264. 10.1111/j.1749-6632.2009.04149.xPubMedCrossRef
53.
Walton NA, Martin DK, Peter EH, Pringle DM, Singer PA: Priority setting and cardiac surgery: a qualitative case study. Health Policy 2007, 80: 444–458. 10.1016/j.healthpol.2006.05.004PubMedCrossRef
54.
Schlander M: The use of cost-effectiveness by the National Institute for Health and Clinical Excellence (NICE): no(t yet an) exemplar of a deliberative process. J Med Ethics 2008, 34: 534–539. 10.1136/jme.2007.021683PubMedCrossRef
55.
van Velden ME, Severens JL, Novak A: Economic evaluations of healthcare programmes and decision making: the influence of economic evaluations on different healthcare decision-making levels. PharmacoEconomics 2005, 23: 1075–1082. 10.2165/00019053-200523110-00002PubMedCrossRef
56.
Williams I, McIver S, Moore D, Bryan S: The use of economic evaluations in NHS decision-making: a review and empirical investigation. Health Technol Assess 2008., 12: iii, ix-iii,175
57.
World Health Organization Regional Committee for South-East Asia: Equity in access to public health. Working paper from the 53rd session of the WHO Regional Committee for South-East Asia, New Delhi, India; 2000. 4–7 September 2000
58.
59.
Giacomini M: How good is good enough? Standards in policy decisions to cover new health technologies. Healthc Policy 2007, 3: 91–101.PubMedCentralPubMed
60.
61.
Goetghebeur MM, Wagner M, Khoury H, Levitt RJ, Erickson LJ, Rindress D: Bridging health technology assessment (HTA) and efficient health care decision making with multicriteria decision analysis (MCDA): Applying the EVIDEM framework to medicines appraisal. Med Decis Making 2011.
62.
Culyer AJ, Bombard Y: An equity framework for health technology assessments. Med Decis Making 2012, 32: 428–441. 10.1177/0272989X11426484PubMedCrossRef
63.
Burls A, Caron L, de Cleret LG, Dondorp W, Harstall C, Pathak-Sen E, et al.: Tackling ethical issues in health technology assessment: a proposed framework. Int J Technol Assess Health Care 2011, 27: 230–237. 10.1017/S0266462311000250PubMedCrossRef
64.
Hawkes N: Health Technology Assessment. NICE goes global. BMJ 2009, 338: b103.PubMed
65.
66.
Diaby V, Laurier C, Lachaine J: A proposed framework for formulary listing in low-income countries. Pharm Med 2011, 25: 71–82.CrossRef
67.
Eichler HG, Pignatti F, Flamion B, Leufkens H, Breckenridge A: Balancing early market access to new drugs with the need for benefit/risk data: a mounting dilemma. Nat Rev Drug Discov 2008, 7: 818–826. 10.1038/nrd2664PubMedCrossRef
68.
Luce BR, Drummond M, Jonsson B, Neumann PJ, Schwartz JS, Siebert U, et al.: EBM, HTA, and CER: clearing the confusion. Milbank Q 2010, 88: 256–276. 10.1111/j.1468-0009.2010.00598.xPubMedCentralPubMedCrossRef
69.
Chalkidou K, Tunis S, Lopert R, Rochaix L, Sawicki PT, Nasser M, et al.: Comparative effectiveness research and evidence-based health policy: experience from four countries. Milbank Q 2009, 87: 339–367. 10.1111/j.1468-0009.2009.00560.xPubMedCentralPubMedCrossRef
70.
Erickson LJ, De WP, Farand L: An analytical framework for immunization programs in Canada. Vaccine 2005, 23: 2470–2476. 10.1016/j.vaccine.2004.10.029PubMedCrossRef
71.
Drummond M, Evans B, LeLorier J, Karakiewicz P, Martin D, Tugwell P, et al.: Evidence and values: requirements for public reimbursement of drugs for rare diseases–a case study in oncology. Can J Clin Pharmacol 2009, 16: e273-e281.PubMed
72.
73.
Baltussen R, Youngkong S, Paolucci F, Niessen L: Multi-criteria decision analysis to prioritize health interventions: Capitalizing on first experiences. Health Policy 2010, 96: 262–264. 10.1016/j.healthpol.2010.01.009PubMedCrossRef
74.
Volpp KG, Loewenstein G, Asch DA: Assessing value in health care programs. JAMA 2012, 307: 2153–2154. 10.1001/jama.2012.3619PubMedCentralPubMed
75.
Culyer AJ: Hic sunt dracones: the future of health technology assessment–one economist's perspective. Med Decis Making 2012, 32: E25-E32. 10.1177/0272989X11426483PubMedCrossRef
Metadata
Title
From efficacy to equity: Literature review of decision criteria for resource allocation and healthcare decisionmaking
Authors
Lalla Aïda Guindo
Monika Wagner
Rob Baltussen
Donna Rindress
Janine van Til
Paul Kind
Mireille M Goetghebeur
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Cost Effectiveness and Resource Allocation / Issue 1/2012
Electronic ISSN: 1478-7547
DOI
https://doi.org/10.1186/1478-7547-10-9

Other articles of this Issue 1/2012

Cost Effectiveness and Resource Allocation 1/2012 Go to the issue

Research

Budgeting based on need: a model to determine sub-national allocation of resources for health services in Indonesia

Review

The role of cognition in cost-effectiveness analyses of behavioral interventions

Methodology

Applying the net-benefit framework for assessing cost-effectiveness of interventions towards universal health coverage

Review

Economic evaluation for first-line anti-hypertensive medicines: applications for the Philippines

Research

Patient- and population-level health consequences of discontinuing antiretroviral therapy in settings with inadequate HIV treatment availability

Research

Field testing of a multicriteria decision analysis (MCDA) framework for coverage of a screening test for cervical cancer in South Africa